A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

I DIDN’T KNOW IT WAS VERY UNPREDICTABLE. A CANCER DIAGNOSIS IS NOT A DEATH SENTENCE. AFTER SIX MONTHS OF CHEMO, SURGERY AND PHYSICAL THERAPY, TIFFANY IS NOW CANCER FREE. SHE ALSO DECIDED TO ...

The SunRISe-2 trial evaluating TAR-200 combined with cetrelimab vs chemoradiation in muscle-invasive bladder cancer has been discontinued.

Women who participated in aerobics while on chemo reported feeling sharper, with a better quality of life However, they did not score better on objective brain function tests WEDNESDAY, Oct. 23, 2024 ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

for adult patients with locally advanced or metastatic urothelial cancer who have previously received platinum-containing chemotherapy and either programmed death receptor-1 (PD-1) or programmed ...

The TROP2-directed antibody-drug conjugate failed to top chemotherapy at extending the lives of bladder cancer patients who had tried a PD-1/L1 therapy and chemo. Detailed data of that flop have ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder ... target only cancer cells, unlike conventional chemotherapy ...